Target & Activity
| Target | Activity | Value |
|---|---|---|
| NQO1 |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| CHO | EC50 | 9.78 μM | Agonist activity at C-terminal beta-galactosidase tagged human recombinant GPR35 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay | [PMID: 23888932] |
| HCT-116 | IC50 | 103 μM | Cytotoxicity against human HCT116 cells assessed as reduction in cell number after 24 hrs by MTT assay | [PMID: 19877692] |
| HCT-116 | IC50 | 19 μM | Cytotoxicity against human HCT116 cells assessed as reduction in cell number after 96 hrs by MTT assay | [PMID: 19877692] |
| HEK-293T | EC50 | 1.3 μM | Agonist activity at human GPR35 expressed in HEK293T cells at 5 uM by EYPF-based beta-arrestin-2 luciferase reporter gene assay | [PMID: 23888932] |
| MIA PaCa-2 | IC50 | 52 μM | Cytotoxicity against human MIAPaCa2 cells assessed as reduction in cell number after 96 hrs by MTT assay | [PMID: 19877692] |
| MIA PaCa-2 | IC50 | 75 μM | Cytotoxicity against human MIA PaCa2 cells by MTT assay | [PMID: 17999461] |
| MIA PaCa-2 | IC50 | 90 μM | Cytotoxicity against human MIAPaCa2 cells assessed as reduction in cell number after 24 hrs by MTT assay | [PMID: 19877692] |